Abstract
Bionanomaterials have recently begun to spark a great amount of interest and could potentially revolutionize biomedical research. Nanoparticles, nanocapsules, and nanotubular structures are becoming attractive options in drug and gene delivery. The size of the delivery vehicles greatly impacts cellular uptake and makes it highly desirable to precisely control the diameter and length of nanocarriers to make uniform nanoparticles at low cost. Carbon nanotubes have shown great potential within the field of drug and gene delivery. However, their insolubility and cytotoxicity could severely delay FDA approval. A desirable alternative would be to fabricate nanostructures from biomaterials such as proteins, peptides, or liposomes, which are already FDA approved. In this article we demonstrate the preparation of protein nanocapsules with both ends sealed using a template-assisted alternate immersion method combined with controlled cleaving. Glucose oxidase nanocapsules with controllable diameter, wall thickness, and length were fabricated and characterized with SEM and TEM. The biochemical activity of glucose oxidase in the form of nanocapsules after processing was confirmed using UV spectrometry. Our future work will explore proteins suitable for drug encapsulation and cellular uptake and will focus on optimizing the cleaving process to gain precise control over the length of the nanocapsules.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Audette GF, van Schaik EJ, Hazes B et al (2004) DNA-binding protein nanotubes: learning from nature’s nanotech examples. Nano Lett 4:1897–1902
Baker LA, Jin P, Martin CR (2005) Biomaterials and biotechnologies based on nanotube membranes. Crit Rev Solid State Mater Sci 30:183–205
Bianco A, Prato M (2003) Can carbon nanotubes be considered useful tools for biological applications? Adv Mater 15:1765–1768
Bianco A, Kostarelos K, Prato M (2005) Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9:674–679
Chen JF, Ding HM, Wang JX et al (2004) Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 25:723–727
Couet J, Biesalski M (2006) Surface-initiated ATRP of N-isopropylacrylamide from initiator-modified self-assembled peptide nanotubes. Macromolecules 39:7258–7268
Courvreur P, Gref R, Andrieux K et al (2006) Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases. Prog Solid State Chem 34:231–235
Cui D, Tian F, Ozkan CS et al (2005) Effect of single walled carbon nanotubes on human HEK293 cells. Toxicol Lett 155:73–85
Decuzzi P, Ferrari M (2007) The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. Biomaterials 28:2915–2922
Fifis T, Gamvrellis A, Crimeen-Irwin B et al (2004) Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against Tumors. J Immunol 173:3148–3154
Gao H, Shi W, Freund LB (2005) Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci U.S.A 102:9469–9474
Gao L, Nie L, Wang T et al (2006) Carbon nanotube delivery of the GFP Gene into mammalian cells. ChemBioChem 7:239–242
Ghadiri MR, Granja JR, Milligan RA et al (1993) Self-assembling organic nanotubes based on a cyclic peptide architecture. Nature 366:324–327
Harashima H, Sakata K, Funato K et al (1994) Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm Res 11:402–406
Hou S, Wang J, Martin CR (2005) Template-synthesized protein nanotubes. Nano Lett 5:231–234
Kakizawa Y, Furukawa S, Ishii A et al (2006) Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG based block anomer. J Control Release 111:368–370
Klumpp C, Kostarelos K, Prato M et al (2006) Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochim Biophys Acta 1758:404–412
Kol N, Adler-Abramovich L, Barlam D et al (2005) Self-assembled peptide nanotubes are uniquely rigid bioinspired supramolecular structures. Nano Lett 5:1343–1346
Langer K, Balthasar S, Vogel V et al (2003) Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm 257:169–180
Liang J, Chik H, Yin A et al (2002) Two-dimensional lateral superlattices of nanostructures: Nonlithographic formation by anodic membrane template. J Appl Phys 91:2544–2546
Lu G, Ai S, Li J (2005) Layer-by-layer assembly of human serum albumin and phospholipids nanotubes based on a template. Langmuir 21:1679–1682
Martin CR, Kohli P (2003) The emerging field of nanotube biotechnology. Nat Rev Drug Discov 2:29–37
Matsumura S, Uemura S, Mihara H (2005) Construction of biotinylated peptide nanotubes for arranging proteins. Mol Biosyst 1:146–148
McKenzie JL, Waid MC, Shi R et al (2003) Decreased functions of astrocytes on carbon nanofiber materials. Biomaterials 25:1309–1317
Neuberger T, Schopf B, Hofmann H et al (2005) Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater 293:483–496
Nishiyama N, Kataoka K (2006) Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 112:630–648
Panarotto D, Briand J, Prato M et al (2004a) Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun 1:16–17
Pantarotto D, Singh R, McCarthy D et al (2004b) Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem Int Ed 43:5242–5246
Park KH, Chhowalla M, Iqbal Z et al (2003) Single-walled carbon nanotubes are a new class of ion channel blockers. J Biol Chem 278:50212–50216
Putnam D (2006) Polymers for gene delivery across length scales. Nat Mater 5:439–451
Shi Kam NW, Dai H (2005) Carbon nanotubes as intracellular protein transporters: Generality and biological functionality. J Am Chem Soc 127:6021–5026
Shvedova A, Castranova V, Kisin E et al (2003) Exposure to carbon nanotube material: Assessment of carbon nanotube cytotixicity using human keratinocyte cells. J Toxicol Environ Health A 66:1909–1926
Spector MS, Selinger JV, Singh A et al (1998) Controlling the morphology of chiral lipid tubules. Langmuir 14:3493–3500
Syte S, Kumon Y, Ishigaki A (1998) Immobilization of glucose oxidase on poly-(L-lysine)-modified polycarbonate membrane. Biotechnol Appl Biochem 27:245–248
Tian Y, He Q, Cui Y et al (2006) Fabrication of protein nanotubes based on layer-by-layer assembly. Biomacromolecules 7:2539–2542
Win KY, Feng SS (2005) Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:2713–2722
Xu ZP, Zeng QH, Lu GQ et al (2006) Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci 61:1027–1040
Acknowledgments
The authors would like to thank the National Nanotechnology Infrastructure Network/Center for Nanostructured Systems at Harvard University for use of their nanofabrication and microscopy facilities. This work is supported in part by the Research Advancement Program of Worcester Polytechnic Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dougherty, S.A., Liang, J. & Kowalik, T.F. Template-assisted fabrication of protein nanocapsules. J Nanopart Res 11, 385–394 (2009). https://doi.org/10.1007/s11051-008-9387-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11051-008-9387-y